Literature DB >> 29763894

The Understanding and Management of Organism Toxicity in Septic Shock.

Kelly Roveran Genga1, Tadanaga Shimada1, John H Boyd1,2, Keith R Walley1,2, James A Russell3,4.   

Abstract

The toxicity caused by different organisms in septic shock is substantially complex and characterized by an intricate pathogenicity that involves several systems and pathways. Immune cells' pattern recognition receptors initiate the host response to pathogens after the recognition of pathogen-associated molecular patterns. In essence, the subsequent activation of downstream pathways may progress to infection resolution or to a dysregulated host response that represents the hallmark of organ injury in septic shock. Likewise, the management of organism toxicity in septic shock is complicated and comprises a multiplicity of suitable targets. In this review, the classic immune responses to pathogens are discussed as well as other factors that are relevant in the pathogenicity of septic shock, including sepsis-induced immune suppression, inflammasome activation, intestinal permeability, and the role of lipids and proprotein convertase subtilisin/kexin type 9. Current therapies aiming to eliminate the organisms causing septic shock, recent and ongoing trials in septic shock treatment, and potential new therapeutic strategies are also explored.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Mediators; PCSK9; Sepsis; Septic shock; Therapies

Mesh:

Substances:

Year:  2018        PMID: 29763894      PMCID: PMC6785648          DOI: 10.1159/000487818

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  69 in total

1.  TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity.

Authors:  Emma M Creagh; Luke A J O'Neill
Journal:  Trends Immunol       Date:  2006-06-27       Impact factor: 16.687

2.  Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines.

Authors:  François Niyonsaba; Hiroko Ushio; Nobuhiro Nakano; William Ng; Koji Sayama; Koji Hashimoto; Isao Nagaoka; Ko Okumura; Hideoki Ogawa
Journal:  J Invest Dermatol       Date:  2006-10-19       Impact factor: 8.551

3.  Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.

Authors:  Mohd H Abdul-Aziz; Helmi Sulaiman; Mohd-Basri Mat-Nor; Vineya Rai; Kang K Wong; Mohd S Hasan; Azrin N Abd Rahman; Janattul A Jamal; Steven C Wallis; Jeffrey Lipman; Christine E Staatz; Jason A Roberts
Journal:  Intensive Care Med       Date:  2016-01-11       Impact factor: 17.440

4.  Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis.

Authors:  Dhruva J Dwivedi; Peter M Grin; Momina Khan; Annik Prat; Ji Zhou; Alison E Fox-Robichaud; Nabil G Seidah; Patricia C Liaw
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

5.  Incremental value of multiplex real-time PCR for the early diagnosis of sepsis in the emergency department.

Authors:  Nora Schaub; Tujana Boldanova; Markus Noveanu; Nisha Arenja; Heinz Hermann; Raphael Twerenbold; Reno Frei; Roland Bingisser; Andrej Trampuz; Christian Mueller
Journal:  Swiss Med Wkly       Date:  2014-02-04       Impact factor: 2.193

Review 6.  Pathophysiological aspects of sepsis: an overview.

Authors:  Yong-Ming Yao; Ying-Yi Luan; Qing-Hong Zhang; Zhi-Yong Sheng
Journal:  Methods Mol Biol       Date:  2015

7.  Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome.

Authors:  E Rintala; H Peuravuori; K Pulkki; L M Voipio-Pulkki; T Nevalainen
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

8.  Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.

Authors:  Cristina D Ciornei; Thorgerdur Sigurdardóttir; Artur Schmidtchen; Mikael Bodelsson
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis.

Authors:  Malte Book; QiXing Chen; Lutz E Lehmann; Sven Klaschik; Stefan Weber; Jens-Christian Schewe; Markus Luepertz; Andreas Hoeft; Frank Stuber
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.

Authors:  Katherine Chang; Catherine Svabek; Cristina Vazquez-Guillamet; Bryan Sato; David Rasche; Strother Wilson; Paul Robbins; Nancy Ulbrandt; JoAnn Suzich; Jonathan Green; Andriani C Patera; Wade Blair; Subramaniam Krishnan; Richard Hotchkiss
Journal:  Crit Care       Date:  2014-01-04       Impact factor: 9.097

View more
  9 in total

1.  Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department.

Authors:  Francesca Innocenti; Anna Maria Gori; Betti Giusti; Camilla Tozzi; Chiara Donnini; Federico Meo; Irene Giacomelli; Maria Luisa Ralli; Alice Sereni; Elena Sticchi; Michela Zari; Francesca Caldi; Irene Tassinari; Maurizio Zanobetti; Rossella Marcucci; Riccardo Pini
Journal:  Intern Emerg Med       Date:  2018-12-07       Impact factor: 3.397

2.  Tackling the Pros and Cons of Inflammation.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2019-08-30       Impact factor: 7.349

3.  Plasma PCSK9 levels and sepsis severity: an early assessment in the emergency department.

Authors:  Francesca Innocenti; Anna Maria Gori; Betti Giusti; Camilla Tozzi; Chiara Donnini; Federico Meo; Irene Giacomelli; Maria Luisa Ralli; Alice Sereni; Elena Sticchi; Irene Tassinari; Rossella Marcucci; Riccardo Pini
Journal:  Clin Exp Med       Date:  2020-08-31       Impact factor: 3.984

4.  Neutrophil extracellular traps mediate m6A modification and regulates sepsis-associated acute lung injury by activating ferroptosis in alveolar epithelial cells.

Authors:  Hao Zhang; Jinlong Liu; Yilu Zhou; Mengdi Qu; Yanghanzhao Wang; Kefang Guo; Ruling Shen; Zhirong Sun; Juan P Cata; Shuofei Yang; Wankun Chen; Changhong Miao
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

5.  The Road Not Taken: Commensal or Virulent Pathogen.

Authors: 
Journal:  J Innate Immun       Date:  2020-06-25       Impact factor: 7.349

6.  Relationship of Zonulin with Serum PCSK9 Levels after a High Fat Load in a Population of Obese Subjects.

Authors:  María Molina-Vega; Daniel Castellano-Castillo; Lidia Sánchez-Alcoholado; Isaac Plaza-Andrade; Gabriel Perera-Martin; Amanda Cabrera-Mulero; Jose Carlos Fernández-García; Bruno Ramos-Molina; Fernando Cardona; Francisco J Tinahones
Journal:  Biomolecules       Date:  2020-05-11

Review 7.  Fluid Therapy in Dogs and Cats With Sepsis.

Authors:  Federico Montealegre; Bridget M Lyons
Journal:  Front Vet Sci       Date:  2021-02-25

8.  Peptidome profiling for the immunological stratification in sepsis: a proof of concept study.

Authors:  Martín Ledesma; María Florencia Todero; Lautaro Maceira; Mónica Prieto; Carlos Vay; Marcelo Galas; Beatriz López; Noemí Yokobori; Bárbara Rearte
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

9.  Effects of Albumin Supplements on In-Hospital Mortality in Patients with Sepsis or Septic Shock: A Systemic Review and Meta-Analysis.

Authors:  Pei Liu; Deyuan Zhi; Yajun Wang; Jin Lin; Meng Zhang; Meili Duan
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.